Australian and American guidelines are recommending the 24-hour Area Under the concentration-time Curve (AUC) based over trough based therapeutic drug monitoring (TDM) for vancomycin. This presentation will be a deep dive into the evidence, different approaches to AUC TDM and building a business case for your executive audience.
Learning objectives:
- Outline recent changes in recommendations to vancomycin dosing and therapeutic drug monitoring
- Explain the implementation process of vancomycin AUC monitoring in an Australian hospital